People who frequently take sleeping medications are 79% more likely to develop dementia than those who never use sleeping pills to aid their rest.
The "love hormone" oxytocin may not play as critical a role in bonding as previously believed. Removing the oxytocin receptor in animal models still resulted in monogamous mating, attachment, and parental bonding behaviors, although females without the receptor produced milk in smaller quantities. Findings reveal parenting and bonding aren't purely dictated by oxytocin receptors.
Exposure to drugs that target tauopathies extended survival, reduced neurodegenerative biomarkers, and functionally reduced aberrant behaviors in female mice, but not in males.
Study reveals how motor memory is consolidated during sleep.
Researchers engineered cells containing customized adhesion molecules that bind to specific cell partners in predictable ways to form complex multicellular entities. The discovery is a major step toward building new tissue and organs.
Pregnant women who participated in group wellness classes for eight weeks were half as likely to suffer depression eight years later compared to women who did not attend the classes.
People with PTSD had a 9% increased risk of hospitalization and an 8% increased risk of death following contracting COVID-19 than people without the disorder. Those with psychosis had a 58% increased risk of death associated with COVID-19, and those with bipolar disorder had a 29% increased risk of dying from coronavirus.
Some senescent (zombie) cells are embedded in young, healthy tissue and promote normal repair from damage, researchers say.
ISRIB, a small molecule that blocks the integrated stress response, can reverse the neural and cognitive effects of a concussion in mice weeks after a brain injury has occurred.
A new mortality prediction model for older patients with Alzheimer's disease can help medical professionals and families determine the best course of action for end-of-life care.
Using neuroimaging and fluid biomarkers from those with the familial form of frontotemporal dementia (FTD), researchers developed models of clinical and biomarker dynamics to determine the temporal sequences of biomarkers and clinical changes in f-FTD before disease progression begins.
Researchers reveal significant differences in gut bacteria in patients with multiple sclerosis compared to those without the autoimmune disease. The study also uncovered novel mechanisms by which the bacteria may influence the disease.
